… a treatment for adults with tardive dyskinesia (TD). The interventional study, expected … broader range of patients with tardive dyskinesia,” Sanjay Keswani, MD, chief … Versus Placebo in Adults With Tardive Dyskinesia. Clinicaltrials.gov. Updated January 26 …

… and dosing VMAT2 inhibitors in tardive dyskinesia. They note that understanding TD …

… address psychiatric diagnosis and tardive dyskinesia diagnosis. Patients must have … benefit for patients with tardive dyskinesia, other hyperkinetic movement disorders … movement disorders like tardive dyskinesia.3 With tardive dyskinesia, VMAT2 inhibitors can …

… all treatment approaches available for tardive dyskinesia and how they are applied …

Prior to 2017, clinicians were limited to options such as vitamin E, amantadine, lowering antipsychotic doses, or switching antipsychotics, but evidence was minimal and results inconsistent. VMAT2 inhibitors introduced the first robust, randomized, placebo …

… clinicians determine whether treatment for tardive dyskinesia is warranted once abnormal movements …

… are essential tools for identifying tardive dyskinesia and distinguishing it from … highlights the importance of differentiating tardive dyskinesia from drug induced Parkinsonism … visits. The panel emphasizes that tardive dyskinesia can emerge weeks, months, …

… can improve early recognition of tardive dyskinesia. Experts emphasize presenting information in … from the slower development of tardive dyskinesia, which highlights the need to … , and help prevent progression of tardive dyskinesia.

… at greatest risk for developing tardive dyskinesia (TD) and how clinicians, particularly …

… psychosocial, and economic burden of tardive dyskinesia (TD), emphasizing its persistent underrecognition … SA, et al. Differentiating tardive dyskinesia: a video-based review of … , Kaye AM. Medication-Induced Tardive Dyskinesia: A Review and Update. Ochsner …